Advanced Nanomaterials for Drug Delivery, 2nd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 1183
Special Issue Editors
Interests: thin films; biomaterials; materials chemistry; cancer research; biomedical engineering; microscopy; tumors; cells
Special Issues, Collections and Topics in MDPI journals
Interests: radioresistant cancer cell biology; tumor cell radiosensitization; DNA damage signaling; mitochondria–nucleus communication; radiation-induced bystander effects; radiation response biomarkers; tumor microenvironment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to a Special Issue of Pharmaceutics entitled “Advanced Nanomaterials for Drug Delivery, 2nd Edition”. It is known that nanoparticle-based systems for therapeutic applications have the ability to pass through biological barriers and target the affected tissues. In the case of drug delivery systems based on nanoparticles, they can enter, and accumulate in, the targeted cells and reach the drug therapeutic target while reducing its systemic toxicity. Moreover, the release of the drug can be controlled and triggered by environmental factors such as pH, light, or enzymes.
This Special Issue will cover recent advancements in nanoparticle design and synthesis for drug delivery applications, characterization, and evaluation, as well as in vitro, in vivo, clinical, or in silico testing. Applications in cancer therapy, antimicrobial or antiviral agents, wound healing, or tissue regeneration can be addressed.
We look forward to receiving your contributions.
Dr. Roxana Cristina Popescu
Dr. Diana Savu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- drug delivery systems
- cancer therapy
- antimicrobial applications
- antiviral applications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
